Traditionally focussed on managing real estate, equity and fixed-income portfolios, family offices in India have broadened their horizons to include alternative investments, particularly in startups ...

Strides Pharma Science in its consolidated financial results for the quarter Q3FY25 ended December 31, 2024 reported revenues of Rs. 1,153.7 crore with a growth 14.6% YoY in Q3FY25. The PAT stood at ...

Strides Pharma Science Ltd (BOM:532531) reports a robust quarter with 13.3% revenue growth and significant debt reduction, while navigating challenges in regulated markets.

Revenue increased 15% YoY at ₹1,153.7 crore from ₹1,005.8 crore in Q3 FY24, marking a consistent business growth.

Arun Kumar, Founder and Executive Chairperson of the Company, has served in various positions on the Board of Strides since its inception. His current appointment as Executive Director is expiring on ...

Strides Pharma Science is well on track to achieve the FY25 outlook of $275 million-$290 million, post-demerger.

Bangalore: Strides Pharma Science Limited has announced that the Company has received an ESG score of 76/100 and CSA score of ...

Adidas AG (OTCQX:ADDYY) (OTCQX:ADDDF) rose again on Wednesday as the investors and analysts latched on to the better-than-anticipated preliminary Q4 earnings report. The German athletic apparel ...

(MENAFN- Adfactors PR) Bangalore, India, January 22, 2025 – Strides Pharma Science Limited ... attained a commendable 87th percentile. Mr. Arun Kumar, Founder & Executive Chairperson, and ...

Strides Pharma Science Ltd announced that its subsidiary, Strides Pharma Global Pte. Limited in Singapore, has received USFDA approval for generic Acetaminophen and Ibuprofen tablets. The tablets, ...